Accurately determining menstrual cycle phases is critical for reproductive health research and clinical trials, yet methodologies for hormone assay timing and frequency lack standardization.
This article provides a comprehensive guide for researchers and drug development professionals on handling informative cluster size (ICS) in biomedical studies.
This article provides a comprehensive guide for researchers and drug development professionals tackling the challenge of hormone verification in resource-constrained environments.
This article synthesizes current evidence and consensus recommendations to address the critical methodological challenges in measuring menstrual cycle endpoints for clinical and research applications.
Subtle menstrual disturbances (SMDs), including anovulation and luteal phase deficiency, are prevalent in athlete populations and can signal underlying health issues like Relative Energy Deficiency in Sport (RED-S), with significant...
This article provides a comprehensive framework for researchers, scientists, and drug development professionals to understand, measure, and account for within-woman variability in menstrual cycle length.
This article provides a systematic framework for researchers, scientists, and drug development professionals to identify, control for, and validate findings against confounding factors in hormone studies.
This article addresses the critical challenge of selection bias in menstrual cycle research, a pervasive issue that compromises data validity and generalizability.
Accurately defining menstrual cycle phases is critical for research on female physiology, drug effects, and athletic performance, yet methodological inconsistencies plague the field.
This article synthesizes current evidence and methodologies for combining diverse menstrual cycle tracking technologies in research and drug development.